Contracts › SPE2DP26F1088
SPE2DP26F1088: 8511797933!Antidote Treatment
Awarded to Meridian Medical Technologies, Llc by Defense Logistics Agency (DLA).
$16.4Mobligated
$16.4Mpotential value
09 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | SPE2DP26F1088 |
|---|---|
| Vehicle | SPE2DP26D0001 |
| Awardee | Meridian Medical Technologies, Llc |
| Awarding agency | Defense Logistics Agency (DLA) |
| Awarding office | DLA TROOP SUPPORT |
| NAICS | 325414 Biological Product (Except Diagnostic) Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | MO |
| Period of performance | 08 December 2025 to 09 September 2026 |
| Potential end | 09 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325414 contracts · All expiring contracts · USASpending record